Kenneth Hoberman
Director · TG THERAPEUTICS, INC.
Individual
- 2025
- Jun 15, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kenneth Hoberman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marlio Charles Mosseri - $916K in NVCT purchases and sales in the last 12 months
- Ron Bentsur - $279K in NVCT purchases and sales in the last 12 months
- Laurence N. Charney - $275K in TGTX purchases and sales in the last 12 months
- Yann Echelard - $163K in TGTX purchases and sales in the last 12 months
- Juan Sanchez - $75K in NVCT purchases and sales in the last 12 months
- Matthew L. Kaplan - $64K in NVCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kenneth Hoberman?
Kenneth Hoberman is a corporate insider, tracked as Director of TG THERAPEUTICS, INC. (TGTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kenneth Hoberman last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 3 filings going back to 2025.
